Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 19 peer-reviewed journal articles Updated
Infectious Disease

Living with Mycetoma: Care, Cure, and Prevention

At a Glance

Living with mycetoma requires wound care, regular medical follow-up, and protection from soil, thorns, and stagnant water. Even after drainage stops and wounds heal, the infection can return months or years later, so checks and early reporting of new lumps or drainage are important.

Living with mycetoma is a long-term journey that extends far beyond the initial diagnosis. Because the infection is chronic and prone to returning (recurrence), successful management requires a combination of daily care, lifestyle adjustments, and persistent medical monitoring [1][2].

Daily Management and Wound Care

If you have active sinus tracts (tunnels that drain fluid from the infection), diligent wound care is essential to prevent secondary bacterial infections, which can lead to sudden pain or fever [3].

  • Hygiene: Keep the affected area clean and follow your care team’s specific instructions regarding dressings. The type of dressing and cleansing method will depend on your wound and available supplies [4].
  • Protection: Avoid exposing open sores to soil, stagnant water, or thorns, as these environments can introduce new bacteria and worsen the infection [5][6].
  • Mobility Support: Nearly 40% of patients experience difficulty walking or moving the affected limb [7]. Using assistive devices like crutches or participating in physiotherapy (rehabilitation exercises) can help maintain joint flexibility and muscle strength [7].

Tracking Progress

To provide a more objective way of measuring your recovery, some clinics use tools like the Mycetoma Activity and Severity Scale (MASS) [8]. While not universally used everywhere, this 20-item tool combines several factors to track how well your treatment is working:

  1. Clinical Features: The size of the mass, the number of active draining sinuses, and whether grains are present [8][9].
  2. Patient-Reported Measures: Your levels of pain and your ability to perform daily activities [8][7].
  3. Investigations: Results from imaging (like ultrasound or MRI) and lab tests [8].

Defining a “Cure” and Follow-up Schedule

Determining when you are “cured” is complex. A clinical cure or remission generally means the resolution of active drainage and grains, healing of sinuses, and absence of evidence of active disease over follow-up [10][11]. Keep in mind that residual fibrosis (scar tissue) or deformity can remain even after the infection is gone.

Even after a clinical cure is reached, regular follow-up is vital. Studies in specific cohorts show that patients who stick to a consistent follow-up schedule have significantly higher odds of a successful long-term outcome [1].

  • Active Treatment: You may need regular visits (sometimes monthly or quarterly) to check drug levels and monitor your health, depending on your regimen [12].
  • Post-Treatment Surveillance: Because recurrence can happen months or even years later, you should continue to have periodic check-ups even after stopping medication. The schedule is set by your treating service [13][2].

Preventing New Infections

The organisms that cause mycetoma are found in the environment, meaning you must take steps to protect yourself [14]. (Note that these measures prevent new inoculations; recurrence of a previous infection requires medical surveillance.)

  • Protective Footwear: Always wear sturdy, closed-toe shoes or boots, especially when working in soil or walking through brush. Walking barefoot is one of the highest risk factors [15][16].
  • Protective Clothing: Wear long pants and gloves during agricultural work or outdoor labor [14].
  • Early Reporting: If you notice a new lump or a small area of drainage near your old scar, see your doctor immediately. Early intervention makes treatment easier [5][17].

Economic and Social Impact

Mycetoma often affects people in their most productive years, leading to significant financial strain [7]. Many patients face high costs for medication, travel to distant clinics, and lost wages due to disability [18]. Additionally, some patients experience social stigma or isolation because of the appearance of the infection [19]. Do not hesitate to discuss these challenges with your healthcare provider; they may be able to connect you with social services or community support programs to assist with travel costs, medication access, and emotional support [7].

Common questions in this guide

How often do I need follow-up visits after mycetoma treatment?
Your schedule depends on your treatment plan and the service caring for you. During active treatment, visits may be monthly or quarterly to check medication levels and overall health; periodic checks remain important after medication ends because mycetoma can return months or years later.
What does a clinical cure mean for mycetoma?
A clinical cure generally means active drainage and grains have stopped, sinus tracts have healed, and follow-up shows no active disease. Scar tissue or deformity may remain even when the infection is no longer active.
How should I care for draining mycetoma wounds at home?
Keep the affected area clean and use the dressing and cleansing methods recommended by your care team, because supplies and wounds differ. Protect open sores from soil, stagnant water, and thorns, and seek prompt medical care for sudden pain or fever because these can signal a secondary infection.
Can mycetoma come back after it appears cured?
Yes. Recurrence can occur months or years after treatment, so periodic medical surveillance is important even after medication stops. Report a new lump or a return of drainage near an old scar promptly.
How can I reduce the chance of a new mycetoma infection?
Wear sturdy closed-toe shoes or boots, especially when working in soil or walking through brush, and use long pants and gloves for agricultural or outdoor work. These measures reduce new inoculations but do not replace follow-up for recurrence of an earlier infection.
Can physiotherapy help with mobility problems from mycetoma?
Yes. Physiotherapy and assistive devices such as crutches can help maintain joint flexibility, muscle strength, and safe movement when an affected limb is difficult to use. Ask your clinician whether a physical therapist with experience in limb rehabilitation is appropriate.
What is the Mycetoma Activity and Severity Scale?
The Mycetoma Activity and Severity Scale, or MASS, is a 20-item tool some clinics use to track disease activity and recovery over time. It combines findings such as the size of the mass, draining sinuses and grains, pain and daily function, plus imaging and laboratory results.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Mycetoma.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my current condition, how frequently should I return for follow-up appointments, and what tests will you use to monitor my progress?
  2. 2.Can you explain my current score on the Mycetoma Activity and Severity Scale (MASS) and what specific changes we are looking for to indicate improvement?
  3. 3.What specific criteria do you use to define a 'clinical cure' for my case, and when will it be safe to stop medication?
  4. 4.Are there specific wound care products or dressing techniques you recommend for my draining sinuses to prevent secondary infections?
  5. 5.Can you refer me to a physical therapist who has experience with limb-saving rehabilitation and mobility exercises?

References

References (19)
  1. 1

    Mycetoma management and clinical outcomes: the Mycetoma Research Center experience.

    Musa EA, Abdoon IH, Bakhiet SM, et al.

    Transactions of the Royal Society of Tropical Medicine and Hygiene 2023; (117(1)):12-21 doi:10.1093/trstmh/trac069.

    PMID: 35903002
  2. 2

    Predictors of Post-operative Mycetoma Recurrence Using Machine-Learning Algorithms: The Mycetoma Research Center Experience.

    Wadal A, Elhassan TA, Zein HA, et al.

    PLoS neglected tropical diseases 2016; (10(10)):e0005007 doi:10.1371/journal.pntd.0005007.

    PMID: 27798643
  3. 3

    Painful mycetoma: a study to understand the risk factors in patients visiting the Mycetoma Research Centre (MRC) in Khartoum, Sudan.

    El-Amin SO, El-Amin RO, El-Sadig SM, et al.

    Transactions of the Royal Society of Tropical Medicine and Hygiene 2025; (119(2)):145-151 doi:10.1093/trstmh/trae093.

    PMID: 39611590
  4. 4

    Mycetoma and the environment.

    Fahal AH, Bakhiet SM

    PLoS neglected tropical diseases 2023; (17(11)):e0011736 doi:10.1371/journal.pntd.0011736.

    PMID: 37971968
  5. 5

    Mycetoma: a clinical dilemma in resource limited settings.

    Emmanuel P, Dumre SP, John S, et al.

    Annals of clinical microbiology and antimicrobials 2018; (17(1)):35 doi:10.1186/s12941-018-0287-4.

    PMID: 30097030
  6. 6

    Eumycetoma and actinomycetoma--an update on causative agents, epidemiology, pathogenesis, diagnostics and therapy.

    Nenoff P, van de Sande WW, Fahal AH, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2015; (29(10)):1873-83 doi:10.1111/jdv.13008.

    PMID: 25726758
  7. 7

    The disabling consequences of Mycetoma.

    Abbas M, Scolding PS, Yosif AA, et al.

    PLoS neglected tropical diseases 2018; (12(12)):e0007019 doi:10.1371/journal.pntd.0007019.

    PMID: 30532253
  8. 8

    Development of the Mycetoma Activity and Severity clinical Scale (MASS): an international Delphi study.

    Chandler DJ, Davey G, Hay RJ, et al.

    The Lancet. Infectious diseases 2025; (25(6)):e345-e352 doi:10.1016/S1473-3099(24)00808-9.

    PMID: 40023182
  9. 9

    Bedside Monitoring of Mycetoma: A Neglected Undertaking in a Neglected Tropical Disease.

    Garg S, Gowda SK, Rout AN, et al.

    Indian journal of dermatology 2026; (71(2)):142-144 doi:10.4103/ijd.ijd_939_24.

    PMID: 41884738
  10. 10

    Epidemiological observations and management challenges in extrapedal mycetoma: A three-decade review of 420 cases.

    Alhaj AAM, Ahmed ES, Hassan A, Fahal AH

    PLoS neglected tropical diseases 2024; (18(5)):e0011841 doi:10.1371/journal.pntd.0011841.

    PMID: 38728359
  11. 11

    Treatment of Madura foot: a systematic review.

    Salim AO, Mwita CC, Gwer S

    JBI database of systematic reviews and implementation reports 2018; (16(7)):1519-1536 doi:10.11124/JBISRIR-2017-003433.

    PMID: 29995713
  12. 12

    [Mycetoma and their treatment].

    Develoux M

    Journal de mycologie medicale 2016; (26(2)):77-85 doi:10.1016/j.mycmed.2016.03.005.

    PMID: 27260344
  13. 13

    [Recidives of Mycetoma after Amputation in Dakar (Senegal)].

    Sarr L, Dembélé B, Limam M, et al.

    Bulletin de la Societe de pathologie exotique (1990) 2019; (112(4)):195-201 doi:10.3166/bspe-2019-0103.

    PMID: 32003194
  14. 14

    Mycetoma: reviewing a neglected disease.

    Verma P, Jha A

    Clinical and experimental dermatology 2019; (44(2)):123-129 doi:10.1111/ced.13642.

    PMID: 29808607
  15. 15

    Epidemiology, risk factors, and awareness of mycetoma among residents in Eastern Sinnar locality, Sudan, 2021.

    Abdallh MGA, Hemeda S, Elmadani M, et al.

    Journal of global health 2025; (15()):04005 doi:10.7189/jogh.15.04005.

    PMID: 39791422
  16. 16

    Individual Risk Factors of Mycetoma Occurrence in Eastern Sennar Locality, Sennar State, Sudan: A Case-Control Study.

    Hassan R, Deribe K, Simpson H, et al.

    Tropical medicine and infectious disease 2022; (7(8)) doi:10.3390/tropicalmed7080174.

    PMID: 36006266
  17. 17

    Madura's foot: reasons for the delay in diagnosis and consequences for the management (a case report).

    Boanimbek B, Aznague Y, Abass GO, et al.

    The Pan African medical journal 2020; (37()):75 doi:10.11604/pamj.2020.37.75.24983.

    PMID: 33244338
  18. 18

    Role of socioeconomic factors in developing mycetoma: Results from a household survey in Sennar State, Sudan.

    Hounsome N, Hassan R, Bakhiet SM, et al.

    PLoS neglected tropical diseases 2022; (16(10)):e0010817 doi:10.1371/journal.pntd.0010817.

    PMID: 36251732
  19. 19

    Extensive perineal Actinomadura pelletieri actinomycetoma-induced urethral stricture: a rare complication.

    Bakheet OE, Hassan MA, Fahal AH

    Transactions of the Royal Society of Tropical Medicine and Hygiene 2021; (115(4)):415-419 doi:10.1093/trstmh/traa166.

    PMID: 33399848

This page is for informational purposes only and does not constitute medical advice. Your treating team can tailor wound care, follow-up, rehabilitation, and recurrence monitoring to your condition.